Trial · NCT03333486
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Relapse Rate | At 1 year | All treated and eligible patients | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | ANC Engraftment Rate, the Percentage of Participants That Had a Successful Engraftment | At 1 year post-transplant | All treated and eligible patients | percentage of participants | NUMBER |
| SECONDARY | Platelet Engraftment Rate, the Percentage of Participants That Had a Successful Engraftment | At 1 year post-transplant | All treated and eligible patients | percentage of participants | NUMBER |
| SECONDARY | Proportion of Participants With Acute Graft Versus Host Disease (GVHD) | At 100 days post-transplant | All treated and eligible patients | proportion of participants | NUMBER |
| SECONDARY | Proportion of Participants With Chronic Graft Versus Host Disease (GVHD) | At 1 year post-transplant | All treated and eligible patients | proportion of participants | NUMBER |
| SECONDARY | Overall Survival | up to 5 years and 8 months | All treated and eligible patients | months | MEDIAN |
| SECONDARY | Progression Free Survival | up to 5 years and 8 months | All treated and eligible patients | months | MEDIAN |
| SECONDARY | Transplant Related Mortality | At 1 year post-transplant | All treated and eligible patients | proportion of participants | NUMBER |
| OTHER_PRE_SPECIFIED | Immune Reconstitution | Up to 1 year | |||
| OTHER_PRE_SPECIFIED | Lymphoid Chimerism Expressed as a Percentage of Donor Cells | At 30 days | All treated and eligible patients. Samples were not obtained at day 100 for 8 subjects. | percentage of donor cells | MEAN |
| OTHER_PRE_SPECIFIED | Myeloid Chimerism Expressed as a Percentage of Donor Cells | At 100 days | All treated and eligible patients. Samples were not obtained at day 100 for 8 subjects. | percentage of donor cells | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03333486/outcomes